ReviewBioMed research international2013
IL-17 in the rheumatologist's line of sight.
Review in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 30 citations in OpenAlex.
- Vitamin D: a potential therapeutic for giardiasis in experimentally infected mice.Scientific reports · 2026Article
- γδCellular & molecular immunology · 2025Article
- Plasma CXCL4-DNA/RNA Complexes and Anti-CXCL4 Antibodies Modulation in an SSc Cohort under Iloprost Treatment.Reports (MDPI) · 2024Article
- The IL-17 family in diseases: from bench to bedside.Signal transduction and targeted therapy · 2023Review
- Personalised Medicine with IL-23 Blockers: Myth or Reality?Journal of Crohn's & colitis · 2022Review
- Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis.Frontiers in immunology · 2021Review
- Literature Overview of the IL-17 Inhibition from Psoriasis to COVID-19.Journal of inflammation research · 2021Review
- Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.Journal of inflammation research · 2020Review
- Article
- Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment.Journal of ophthalmology · 2017Review
- Immunological and pathological investigations in equine experimental uveitis.Veterinary research communications · 2016Article
- Induction of Interleukin-22 (IL-22) production in CD4Annals of dermatology · 2016Article
- IL17A and IL17F gene polymorphisms in patients with rheumatoid arthritis.BMC musculoskeletal disorders · 2016Article
- Serum Heme Oxygenase-1 and BMP-7 Are Potential Biomarkers for Bone Metabolism in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis.BioMed research international · 2016Article
- Interleukin-17A promotes the formation of inflammation in the lung tissues of rats with pulmonary fibrosis.Experimental and therapeutic medicine · 2015Article
- Milk fat globule E-8 and interleukin 17 in systemic lupus erythematosus: partners in crime?Reumatologia · 2015Article
- Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside.Auto- immunity highlights · 2014Review
- Interleukin-17 in human inflammatory diseases.Postepy dermatologii i alergologii · 2014Review
- Emerging therapies for noninfectious uveitis: what may be coming to the clinics.Journal of ophthalmology · 2014Review
- Commercial bovine proteoglycan is highly arthritogenic and can be used as an alternative antigen source for PGIA model.BioMed research international · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past decades, the identification of several new cytokines, including interleukin (IL)-17 and IL-23, and of new T helper cell subsets, including Th17 cells, has changed the vision of immunological processes. The IL-17/Th17 pathway plays a critical role during the development of inflammation and autoimmunity, and targeting this pathway has become an attractive strategy for a number of diseases. This review aims to describe the effects of IL-17 in the joint and its roles in the development of autoimmune and inflammatory arthritis. Furthermore, biotherapies targeting directly or indirectly IL-17 in inflammatory rheumatisms will be developed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.